A detailed history of Td Asset Management Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 148,184 shares of MRNA stock, worth $6.43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
148,184
Previous 162,137 8.61%
Holding current value
$6.43 Million
Previous $19.3 Million 48.56%
% of portfolio
0.01%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$63.64 - $125.14 $887,968 - $1.75 Million
-13,953 Reduced 8.61%
148,184 $9.9 Million
Q2 2024

Aug 02, 2024

BUY
$101.21 - $166.61 $1.98 Million - $3.27 Million
19,599 Added 13.75%
162,137 $19.3 Million
Q1 2024

May 08, 2024

BUY
$85.37 - $115.44 $139,921 - $189,206
1,639 Added 1.16%
142,538 $15.2 Million
Q4 2023

Feb 12, 2024

SELL
$69.51 - $104.43 $1.3 Million - $1.95 Million
-18,692 Reduced 11.71%
140,899 $14 Million
Q3 2023

Oct 27, 2023

SELL
$96.41 - $126.61 $369,539 - $485,296
-3,833 Reduced 2.35%
159,591 $16.5 Million
Q2 2023

Aug 09, 2023

SELL
$118.5 - $160.53 $2.39 Million - $3.24 Million
-20,171 Reduced 10.99%
163,424 $19.9 Million
Q1 2023

May 10, 2023

SELL
$135.66 - $197.02 $5.93 Million - $8.61 Million
-43,723 Reduced 19.23%
183,595 $28.2 Million
Q4 2022

Feb 06, 2023

SELL
$118.38 - $210.04 $6.25 Million - $11.1 Million
-52,754 Reduced 18.84%
227,318 $40.8 Million
Q3 2022

Nov 07, 2022

BUY
$118.07 - $194.18 $174,625 - $287,192
1,479 Added 0.53%
280,072 $33.1 Million
Q2 2022

Aug 04, 2022

BUY
$117.13 - $176.59 $3.22 Million - $4.86 Million
27,507 Added 10.96%
278,593 $39.8 Million
Q1 2022

May 10, 2022

BUY
$126.46 - $235.05 $55,768 - $103,657
441 Added 0.18%
251,086 $43.3 Million
Q4 2021

Feb 10, 2022

SELL
$225.82 - $368.51 $817,468 - $1.33 Million
-3,620 Reduced 1.42%
250,645 $63.7 Million
Q3 2021

Nov 09, 2021

BUY
$221.9 - $484.47 $1.23 Million - $2.68 Million
5,529 Added 2.22%
254,265 $97.9 Million
Q2 2021

Aug 11, 2021

BUY
$129.91 - $234.98 $10.1 Million - $18.3 Million
77,922 Added 45.62%
248,736 $88 Million
Q1 2021

May 14, 2021

BUY
$109.18 - $185.98 $3.87 Million - $6.58 Million
35,402 Added 26.14%
170,814 $22.4 Million
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $1.81 Million - $4.68 Million
27,523 Added 25.51%
135,412 $14.1 Million
Q3 2020

Nov 10, 2020

BUY
$54.34 - $94.85 $2.65 Million - $4.62 Million
48,688 Added 82.24%
107,889 $7.63 Million
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $1.03 Million - $2.79 Million
34,882 Added 143.44%
59,201 $3.8 Million
Q1 2020

May 15, 2020

BUY
$17.78 - $31.58 $432,391 - $767,994
24,319 New
24,319 $728,000
Q4 2019

Feb 11, 2020

SELL
$13.93 - $21.28 $289,827 - $442,751
-20,806 Closed
0 $0
Q3 2019

Nov 07, 2019

BUY
$12.26 - $18.07 $17,164 - $25,298
1,400 Added 7.21%
20,806 $331,000
Q2 2019

Aug 01, 2019

BUY
$13.7 - $28.34 $265,862 - $549,966
19,406 New
19,406 $284,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $17B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.